Sectra to Acquire Oxipit to Strengthen Autonomous AI in Radiology

Sectra has entered into an agreement to acquire Oxipit, a Lithuanian company specializing in AI-based radiology solutions, announced in a press release. The transaction is expected to close in March 2026, pending customary conditions.

Oxipit developed ChestLink, an autonomous AI system certified under CE Class IIb regulations for chest X-ray analysis. The software automatically identifies and clears high-confidence normal exams from radiologists’ worklists, allowing them to focus on more complex cases. It is already available through Sectra’s Amplifier Marketplace for AI.

Following the acquisition, Oxipit will operate as a dedicated AI development center within Sectra’s Imaging IT Solutions division. The integration will maintain Sectra’s vendor-neutral Amplifier ecosystem, giving healthcare providers access to a range of vetted AI tools. The deal is financed with Sectra’s own funds, including an upfront payment and contingent consideration linked to future milestones. Financial terms were not disclosed.